tiprankstipranks
Trending News
More News >

Sino Biopharmaceutical Announces 2025 Annual General Meeting Details

Story Highlights
  • Sino Biopharmaceutical will hold its annual general meeting on June 10, 2025.
  • Key agenda includes financial statement adoption, director re-elections, and share issuance authorization.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
Sino Biopharmaceutical Announces 2025 Annual General Meeting Details

Confident Investing Starts Here:

An announcement from Sino Biopharmaceutical ( (HK:1177) ) is now available.

Sino Biopharmaceutical Limited announced the details of its upcoming annual general meeting scheduled for June 10, 2025. Key agenda items include the adoption of financial statements for 2024, approval of a final dividend, re-election of several directors, and the re-appointment of Ernst & Young as auditors. The meeting will also consider resolutions to authorize the board to issue additional shares, potentially impacting the company’s capital structure and shareholder value.

More about Sino Biopharmaceutical

Sino Biopharmaceutical Limited is a company incorporated in the Cayman Islands, operating within the pharmaceutical industry. The company is primarily focused on the development, manufacturing, and distribution of biopharmaceutical products.

YTD Price Performance: 26.92%

Average Trading Volume: 2,117

Technical Sentiment Signal: Sell

Current Market Cap: $9.25B

Learn more about 1177 stock on TipRanks’ Stock Analysis page.

Disclaimer & Disclosure

Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.

Report an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App